BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16740690)

  • 1. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
    Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
    Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
    Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Abdelmohsen K; Gorospe M; Kern SE
    Cell Cycle; 2006 May; 5(10):1090-3. PubMed ID: 16721048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
    Wang L; Pan Y; Dai JL
    Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
    Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
    Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
    Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
    Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
    Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
    Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells.
    Cazillis M; Bringuier AF; Delautier D; Buisine M; Bernuau D; Gespach C; Groyer A
    Oncogene; 2004 Jun; 23(27):4735-44. PubMed ID: 15122334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
    Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
    Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MKK4 acts as a potential tumor suppressor in ovarian cancer.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.
    Finegan KG; Tournier C
    Cancer Res; 2010 Jul; 70(14):5797-806. PubMed ID: 20610622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mitogen-activated protein kinase kinase 4 in cancer.
    Whitmarsh AJ; Davis RJ
    Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
    Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
    Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.
    Ahn YH; Yang Y; Gibbons DL; Creighton CJ; Yang F; Wistuba II; Lin W; Thilaganathan N; Alvarez CA; Roybal J; Goldsmith EJ; Tournier C; Kurie JM
    Mol Cell Biol; 2011 Nov; 31(21):4270-85. PubMed ID: 21896780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.